AXS-12, known as reboxetine back when it was available as an antidepressant in the United States, may decrease cataplexy ...

University of California, Davis, researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that ...

The National Institute for Standards and Technology’s new harm reduction initiative is helping prevent needless deaths.

The U.S. Food and Drug Administration announced it is shifting away from animal testing in the development of monoclonal ...

In a landmark decision poised to revolutionize drug development, the U.S. Food and Drug Administration (FDA) has announced a ...

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with ...

AI-driven drug discovery firms rallied on Friday after the U.S. Food and Drug Administration (FDA) announced an initiative to ...

The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...

The FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.

The National Cancer Institute’s Investigational New Drug program facilitates collaboration, not collusion, with industry for ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...